MassPRIM Commits $1.1B to Alternatives
Written by: Koncheng Moua, Director of Data Management and Strategy
Massachusetts Pension Reserves Investment Board has disclosed five investments totaling up to $1.1 billion.
In private equity, $300 million was committed to Hellman & Friedman Capital Partners XI. $285 million was committed to buyout fund, GTCR XIV. $335 million was allocated to buyout fund TA XV, and $35 million was committed to growth equity fund, TA Select Opportunities Fund III.
Within MassPRIM’s Other Credit Opportunities, $150 million was committed to Biopharma Credit Investments V, a fund managed by Pharmakon Advisors that focuses on senior secured loans backed by FDA approved products.
In addition, MassPRIM increased their private equity target allocation range from 12%-18% to 13%-19%. They are targeting a commitment goal of $2.2 billion to $3 billion to private equity funds and co-investments.
For more public pension insights and a comprehensive library of public plan minutes, we would love to offer you a free trial of Dakota Marketplace!
